Amoxicillin/clavulanic acid (INN) or co-amoxiclav (BAN) is an antibiotic useful for the treatment of a number of bacterial infections. It is a combination antibiotic consisting of amoxicillin trihydrate, a β-lactam antibiotic, and potassium clavulanate, a β-lactamase inhibitor. This combination results in an antibiotic with an increased spectrum of action and restored efficacy against amoxicillin-resistant bacteria that produce β-lactamase.

Starting at
| Amoxicillin | Penicillin antibiotic | 
| Clavulanic acid | Beta-lactamase inhibitor | 
| Trade names | Augmentin, Clavamox, Tyclav, other | 
| AHFS/Drugs.com | monograph | 
| MedlinePlus | a685024 | 
| Licence data | US FDA:link | 
| Pregnancy category  | 
 AU: B1  | 
| Legal status | 
 AU: S4 (Prescription only)  | 
| Routes of administration  | 
oral, intravenous | 
| CAS Number | 74469-00-4 | 
| ATC code | J01CR02 | 
| PubChem | CID: 6435923 | 
| ChemSpider | 4940608 | 
| ChEMBL | CHEMBL1697738 | 
			
        
    
			
        
    
			
        
    
			
        
    
                            
Reviews
There are no reviews yet.